Urgent amendment of the sartan monographs in the European Pharmacopoeia
29. März 2021 – The five revised monographs on sartans with a tetrazole ring, candesartancilexetil, irbesartan, losartan potassium, olmesartan medoxomil and valsartan, will enter into force on 1 April 2021. These revised monographs have not been published in Pharmeuropa for public inspection as the changes made are in line with the CHMP recommendations.
For more information, see here.